Algerian Radio
Several US pharmaceutical companies highlighted, this Monday in Algiers, their interest in cooperating with Algerian operators to support innovation in the health sector.
This came within the framework of the "High-Level Forum to Drive Innovation through Strategic Cooperation between Algeria and the United States."
At an event organized by the American Chamber of Commerce in Algeria (AmCham), several US pharmaceutical companies focused on their intentions to contribute to supporting health development in Algeria.
The Chargé d'Affaires at the US Embassy in Algeria, Ryan Balserak, stated the "ability of US companies to contribute with advanced science and technology."
He noted working in close cooperation with professionals, institutions, and ministries to help drive growth in the healthcare sector in Algeria.
He pointed out that "long-standing and multi-faceted bilateral relations on the economic level are witnessing growth in several sectors," citing energy, agriculture, and technology as examples.
The American diplomat added: "The forum contributes to continuing to build on this foundation and strengthening cooperation in the vital field of healthcare."
Ryan Balserak reiterated his country's support for initiatives that strengthen bilateral economic relations and encourage innovation.
For his part, the President of the American Chamber of Commerce in Algeria, Warren Murdoch, explained that holding the forum "reflects a shared ambition to strengthen the health system in Algeria."
He focused on responsible, sustainable, and world-class pharmaceutical innovation.
He noted that innovation "is no longer just a driver of growth, but a pillar of national health resilience and an essential tool for enhancing industrial competitiveness."
He linked the foregoing to highlighting the ability of modern health systems to adapt to situations and integrate scientific and technological progress.
The AmCham President praised "the ongoing reforms in Algeria and investments directed at modernizing the health system."
He considered that they "provide promising foundations for accelerating scientific progress and enhancing local capabilities," estimating that they "pave the way for sustainable skills development and strengthening integration into global value chains."
Doria Oughlis, Vice President of the Chamber and director of a US laboratory in Algeria, highlighted the desire of her country's companies to push towards joint work.
She focused on the importance of accelerating effective access to innovation for the benefit of patients. She also highlighted that Algerian-American cooperation allows for the provision of truly innovative treatments.
In turn, the speakers highlighted the role of pharmaceutical companies in enhancing innovation as a socio-economic value and ways to create a sustainable environment for innovation.
They pointed to the necessity of protecting patents, as well as enhancing national capabilities in the field of clinical research.
This forum saw the presence of representatives from a number of ministerial sectors and the Rector of the University of Health Sciences, Merzak Gharnaout.
Also participating were the President of the Algerian Council of Economic Renewal (CREA), Kamel Moula, a representative of the General Directorate of Customs, representatives of professional organizations, as well as experts and researchers.
